Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1

Journal of Investigative Dermatology

Volumn 114, Issue 2, 2000, Pages 328-333

  Katiyar, Santosh K ^a   Matsui, Mary S ^b   Mukhtar, Hasan ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Estee Lauder Inc   (United States)

Author keywords

Cytochromes P450; Human skin; Immunohistochemistry; Reverse transcription polymerase chain reaction; Ultraviolet

Indexed keywords

CYTOCHROME P450 1B1; CYTOCHROME P450 ISOENZYME; ETHOXYRESORUFIN DEETHYLASE; UNCLASSIFIED DRUG;

ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN ALLERGY; SKIN CARCINOMA; SOLAR RADIATION; ULTRAVIOLET B RADIATION;

EID: 0034046957     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00876.x     Document Type: Article

References (42)

1. Ahmad N, Agarwal R, Mukhtar H: Cytochrome P-450 and drug development for skin diseases. Skin Pharmacol 9:231-241, 1996
2. Alexander DL, Eltom SE, Jefcoate CR: Ah receptor regulation of CYP 1B1 expression in primary mouse embryo-derived cells. Cancer Res 57:4498-4506, 1997
3. Baron JM, Zwadlo-Klarwasser G, Jugert F, Hamann W, Rubben A, Mukhtar H, Merk HF: Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol 56:1105-1110, 1998
4. Bickers DR, Kappas A: Human skin aryl hydrocarbon hydroxylase induction by coal tor. J Clin Invest 62:1061-1068, 1978
5. Bickers DR, Dutta-Choudhury T, Mukhtar H: Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity. Mol Pharmacol 1:239-247, 1982
6. Boring CC, Squires TS, Tong T: Cancer statistics, 1991. CA Cancer J Clin 41:19-36, 1991
7. Boulenc X, Bourrie M, Fabre I, Roque C, Joyeux H, Berger Y, Fabre G: Regulation of cytochrome P4501A1 gene expression in a human intestinal cell line, Caco-2. J Pharmacol Exp Ther 263:1471-1478, 1992
8. Bradford M: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 227:248-254, 1976
9. Brash DE, Rudolph JA, Simon JA, et al: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128, 1991
10. Conney AH: Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. GHA Clowes Memorial Lecture. Cancer Res 42:4875-4917, 1982
11. Donawho CK, Kripke ML: Evidence that the local effect of ultraviolet radiation on the growth of murine melanomas is immunologically mediated. Cancer Res 51:4176-4181, 1991
12. Falk HL, Kotin P, Mehler A: Polycyclic hydrocarbons as carcinogens for man. Arch Environ Health 8:721-731, 1964
13. Fuchs E: Epidermal differentiation: The bare essentials. J Cell Biol 111:2807-2814, 1990
14. Glass AG, Hoover RN: The emerging epidemic of melanoma and squamous cell skin cancer. J Am Med Assoc 262:2097-2110, 1989
15. Gonzalez FJ: The molecular biology of the cytochrome P 450s. Pharmacol Rev 40:243-288, 1989
16. Guo JF, Brown R, Rothwell CE, Bernstein IA: Levels of cytochrome P-450-mediated aryl hydrocarbon hydroxylase (AHH) are higher in differentiated than germinative cutaneous kerarinocytes. J Invest Dermatol 94:86-93, 1990
17. Hammerberg C, Duraiswamy N, Cooper KD: Reversal of immunosuppression inducible through ultraviolet-exposed skin by m vivo anti-CD11b treatment. J Immunol 157:5254-5261, 1996
18. Hankinson O: The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307-340, 1995
19. Ioannides C, Parke DV: The cytochrome P450, 1 gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metab Rev 22:1-85, 1990
20. Jones CL, Reiners JJ Jr: Differentiation status of cultured murine keratinocytes modulates induction of genes responsive to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Biochem Biophys 347:163-173, 1997
21. Kang K, Kubin M, Cooper KD, Lessin SR, Trinchieri G, Rook AH: IL-12 synthesis by human Langerhans cells. J Immunol 156:1402-1407, 1996
22. Katiyar SK, Agarwal R, Mukhtar H: Introduction: sources, occurrence, nomenclature, and carcinogenicity of polycyclic aromatic hydrocarbons. In: Rathore HS ed. Handbook of Chromatography. Boca Raton, FL, CRC Press, 1993, pp 1-17
23. Katiyar SK, Korman NJ, Mukhtar H, Agarwal R: Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst 89:556-566, 1997
24. Kinoshita N, Gelboin HV: The role of aryl hydrocarbon hydroxylase in 7,12-dimethylbenz (a) anthracene skin tumorigenesis: on the mechanism of 7,8-benzaflavone inhibition of tumorigenesis. Cancer Res 32:1329-1339, 1972
25. Kligman LH, Akin FJ, Kligman AM: Sunscreens prevent ultraviolet photocarcinogenesis. J Am Acad Dermatol 3:30-35, 1980
26. Kress S, Greenlee WF: Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res 57:1264-1269, 1997
27. Marikar Y, Wang ZQ, Duell EA, Petkovich M, Voorhees JJ, Fisher GJ: Retinoic acid receptors regulate expression of retinoic acid 4-hydroxylase that specifically inactivates all-trans retinoic acid in human keratinocyte HaCaT cells. J Invest Dermatol 111:434-439, 1998
28. Mukhtar H, Link CM, Cherniack E, Kushiner DM, Bickers DR: Effect of topical application of defined constituents of coal tar on skin and liver aryl hydrocarbon hydroxylase and 7-ethoxycoumarin deethylase activities. Toxicol Appl Pharmacol 64:541-549, 1982
29. Mukhtar H, Das M, Bickers DR: Skin tumor initiating activity of therapeutic crude coal tar as compared to other polycyclic aromatic hydrocarbons in SENCAR mice. Cancer Lett 31:147-151, 1986a
30. Mukhtar H, DelTito BJ Jr, Matgouranis PM, Das M, Asokan P, Bickers DR: Additive effects of ultraviolet B and crude coal tar on cutaneous carcinogen metabolism: possible relevance to the tumorigenicity of the Goeckerman regimen. J Invest Dermatol 87:348-353, 1986b
31. Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD, Melvin WT: Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57:3026-3031, 1997
32. Nebert DW: Drug-metabolizing enzymes in ligand-modulated transcription. Biochem Pharmacol 47:25-37, 1994
33. Nelson DR, Koymans L, Kamataki T, et al: P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1-42, 1996
34. Nerurkar PV, Park SS, Thomas PE, Nims RW, Lubet RA: Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem Pharmacol 46:933-943, 1993
35. Raza H, Agarwal R, Bickers DR, Mukhtar H: Purification and molecular characterization of β-naphthoflavone inducible cytochrome P450 from rat epidermis. J Invest Dermatol 98:233-240, 1992
36. Reiners JJ Jr, Cantu AR, Thai G, Scholler A: Differential expression of basal and hydrocarbon-induced cytochrome P450 monooxygenase and quinone reductase activities in subpopulations of murine epidermal cells differing in their stages of differentiation. Drug Metab Dispos 20:360-366, 1992
37. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR: Activation of a chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 56:2979-2984, 1996
38. Stauber KL, Laskin JD, Yurkow EJ, Thomas PE, Laskin DL, Conney AH: Flow cytometry reveals subpopulations of murine epidermal cells that are refractory to induction of cytochrome P-450 1A1 by β-naphthoflavone. J Pharmacol Exp Ther 273:967-976, 1995
39. Taylor MC, McKay JA, Murray GI, Greenlee WF, Marcus CB, Burke MD, Melvin WT: Cytochrome P450 1B1 expression in human malignant tumours. Biochem Soc Trans 24:3285-3335, 1996
40. Wallcave L, Garcia H, Feldman R, Lijinsky W, Shubik P: Skin tumorigenesis in mice by petroleum asphalts and coal-tar pitches of known polynuclear aromatic hydrocarbon content. Toxicol Appl Pharmacol 18:41-52, 1971
41. Whitlock JP Jr: Mechanistic aspects of dioxin action. Chem Res Toxicol 6:754-763, 1993
42. 53 in the onset of skin cancer. Nature 372:773-776, 1994